               SEQUENCE LISTING

<110> Dompé Farmaceutici S.p.A.

<120>  PREVENTION OF SPIKE PROTEIN BASED COVID-19 VACCINES SIDE EFFECTS

<130> 252EP

<160> 9

<170> BiSSAP 1.3.6

<210> 1
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> SPIKELMX1 aa positions 812 - 828

<400> 1
Pro Ser Lys Arg Ser Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr 
1               5                   10                  15      
Leu 
    

<210> 2
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA1LXD1 aa positions 627 - 643

<400> 2
Ser Gln Thr Ser His Lys Leu Val Gln Leu Leu Thr Thr Thr Ala Glu 
1               5                   10                  15      
Gln 
    

<210> 3
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA2LDX1 aa positions 635 - 651

<400> 3
Ser Lys Gly Gln Thr Lys Leu Leu Gln Leu Leu Thr Thr Lys Ser Asp 
1               5                   10                  15      
Gln 
    

<210> 4
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA1LXD2 aa positions 684 - 700

<400> 4
Thr Glu Arg His Lys Ile Leu His Arg Leu Leu Gln Glu Gly Ser Pro 
1               5                   10                  15      
Ser 
    

<210> 5
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA2LDX2 aa positions 684 - 700

<400> 5
Lys Glu Lys His Lys Ile Leu His Arg Leu Leu Gln Asp Ser Ser Ser 
1               5                   10                  15      
Pro 
    

<210> 6
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA1LXD3 aa positions 743 - 759

<400> 6
Ser Lys Asp His Gln Leu Leu Arg Tyr Leu Leu Asp Lys Asp Glu Lys 
1               5                   10                  15      
Asp 
    

<210> 7
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA2LDX3 aa positions 739 - 755

<400> 7
Lys Lys Glu Asn Ala Leu Leu Arg Tyr Leu Leu Asp Lys Asp Asp Thr 
1               5                   10                  15      
Lys 
    

<210> 8
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA1LXD4 aa positions 907 - 923

<400> 8
Gln Cys Ile Ser Ser Gln Leu Asp Glu Leu Leu Cys Pro Pro Thr Thr 
1               5                   10                  15      
Val 
    

<210> 9
<211> 17
<212> PRT
<213> Artificial Sequence


<220> 
<223> NCOA2LDX4 aa positions 1073 - 1089

<400> 9
Pro Ser Asp Glu Gly Ala Leu Leu Asp Gln Leu Tyr Leu Ala Leu Arg 
1               5                   10                  15      
Asn 
    

